Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion

• Sarah Halford,
• Susan Wan,
• Ilaria Dragoni,
• Julie Silvester,
• Bobojon Nazarov,
• Daniel Anthony,
• Suzie Anthony,
• Emma Ladds,
• John Norrie,
• Kevin Dhaliwal,
• and the CDD SPIKE-1 Project Team

Affiliations

Sarah Halford

Cancer Research UK Centre for Drug Development

Susan Wan

Cancer Research UK Centre for Drug Development

Ilaria Dragoni

Cancer Research UK Centre for Drug Development

Julie Silvester

Cancer Research UK Centre for Drug Development

Bobojon Nazarov

Latus Therapeutics

Daniel Anthony

University of Oxford

Suzie Anthony

Oxford University Hospitals NHS Foundation Trust

Emma Ladds

Nuffield Department of Primary Care Health Sciences, University of Oxford

John Norrie

The University of Edinburgh

Kevin Dhaliwal

The University of Edinburgh

and the CDD SPIKE-1 Project Team

Cancer Research UK Centre for Drug Development